Antiretroviral Treatment of HIV/AIDS During Pregnancy
- PMID: 37010862
- PMCID: PMC10390091
- DOI: 10.1001/jama.2023.5076
Antiretroviral Treatment of HIV/AIDS During Pregnancy
Plain language summary
This Insights in the Women’s Health series describes the availability, timing, and risks of antiretroviral therapy (ART) in pregnant individuals who have HIV infection.
Conflict of interest statement
Dr Mofenson serves as a paid consultant to the World Health Organization on issues related to antiretroviral drugs in pregnancy, and her employer has received funding from ViiV for a pilot birth outcomes surveillance project in Eswatini. No other disclosures were reported.
References
-
- Flynn PM, Taha TE, Cababasay M, et al. PROMISE Study Team. Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for the duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open-label clinical trial. J Acquir Immune Defic Syndr. 2018;77(4):383–392. doi:10.1097/QAI.0000000000001612 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical